Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.

Abstract:

:Allogeneic stem cell transplantation (SCT) is curative for hemophagocytic lymphohistiocytosis (HLH). However, patients frequently have significant morbidity before transplantation and there is high transplant-related mortality (TRM). Because first-degree HLH is caused by immune dysregulation, a reduced-intensity conditioned (RIC) regimen might be sufficient for cure while decreasing the TRM. Twelve patients with HLH underwent RIC SCT from a matched family/unrelated or haploidentical donor. Eleven were conditioned with fludarabine/melphalan with additional busulphan for haploidentical grafts. One received fludarabine and 2-Gy total body irradiation (TBI). All patients showed engraftment at a median of 14 days. Nine of 12 (75%) are alive and in complete remission (CR) a median of 30 months (range, 9-73 months) after SCT. Two patients died from pneumonitis and one from hepatic rupture. Four patients developed acute graft-versus-host disease (GVHD) and 3 have chronic GVHD. Three of 9 survivors have mixed chimerism but remain free of disease. In summary, RIC compares favorably to conventional SCT with long-term disease control in surviving patients despite a significant incidence of mixed chimerism.

journal_name

Blood

journal_title

Blood

authors

Cooper N,Rao K,Gilmour K,Hadad L,Adams S,Cale C,Davies G,Webb D,Veys P,Amrolia P

doi

10.1182/blood-2005-05-1819

subject

Has Abstract

pub_date

2006-02-01 00:00:00

pages

1233-6

issue

3

eissn

0006-4971

issn

1528-0020

pii

2005-05-1819

journal_volume

107

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

    abstract::Clinical trials have been started with the aim of inducing tumor immunity by blocking the immunosuppressive action of indoleamine-2,3-dioxygenase (IDO) with the IDO2-inhibitor dextro-1-methyl-tryptophan (D-1MT). Here we show that human dendritic cells (DCs) express both IDO-1 and IDO-2, but that only IDO1 mediates try...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-10-116111

    authors: Lob S,Konigsrainer A,Schafer R,Rammensee HG,Opelz G,Terness P

    更新日期:2008-02-15 00:00:00

  • The polyadenylation site mutation in the alpha-globin gene cluster.

    abstract::In a previous study, we described a form of nondeletion alpha-thalassemia (alpha T Saudi alpha) found in subjects of Saudi Arabian origin. In the current study, using synthetic oligoprobe hybridization and restriction enzyme analysis, we have demonstrated that the molecular basis of alpha T Saudi alpha is due solely t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Thein SL,Wallace RB,Pressley L,Clegg JB,Weatherall DJ,Higgs DR

    更新日期:1988-02-01 00:00:00

  • The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.

    abstract::Numerous studies have suggested that iron (Fe) chelators such as desferrioxamine (DFO) may be useful antitumor agents (Blatt and Stitely, Cancer Res 47:1749, 1987; Becton and Bryles, Cancer Res 48:7189, 1988). Recent work with several analogues of the lipophilic Fe chelator, pyridoxal isonicotinoyl hydrazone (PIH), in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Richardson DR,Tran EH,Ponka P

    更新日期:1995-12-01 00:00:00

  • Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors.

    abstract::We have developed a novel cotransplantation system in which gene-transduced human CD34+ progenitor cells are transplanted into immunodeficient (bnx) mice together with primary human bone marrow (BM) stromal cells engineered to produce human interleukin-3 (IL-3). The IL-3-secreting stroma produced sustained circulating...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nolta JA,Hanley MB,Kohn DB

    更新日期:1994-05-15 00:00:00

  • A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation.

    abstract::Translation of small interfering RNA (siRNA)-based approaches into practical therapeutics is limited because of lack of an effective and cell-specific delivery system. Herein, we present a new method of selectively delivering siRNA to dendritic cells (DCs) in vivo using CD40 siRNA-containing immunoliposomes (siILs) th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151191

    authors: Zheng X,Vladau C,Zhang X,Suzuki M,Ichim TE,Zhang ZX,Li M,Carrier E,Garcia B,Jevnikar AM,Min WP

    更新日期:2009-03-19 00:00:00

  • Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

    abstract::Intravascular hemolysis describes the relocalization of heme and hemoglobin (Hb) from erythrocytes to plasma. We investigated the concept that erythrocyte membrane microparticles (MPs) concentrate cell-free heme in human hemolytic diseases, and that heme-laden MPs have a physiopathological impact. Up to one-third of c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-589283

    authors: Camus SM,De Moraes JA,Bonnin P,Abbyad P,Le Jeune S,Lionnet F,Loufrani L,Grimaud L,Lambry JC,Charue D,Kiger L,Renard JM,Larroque C,Le Clésiau H,Tedgui A,Bruneval P,Barja-Fidalgo C,Alexandrou A,Tharaux PL,Boulanger CM

    更新日期:2015-06-11 00:00:00

  • Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonist.

    abstract::The human interleukin-3 receptor (IL-3R) is expressed on myeloid, lymphoid, and vascular endothelial cells, where it transduces IL-3-dependent signals leading to cell activation. Although IL-3R activation may play a role in hematopoiesis and immunity, its aberrant expression or excessive stimulation may contribute to ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sun Q,Woodcock JM,Rapoport A,Stomski FC,Korpelainen EI,Bagley CJ,Goodall GJ,Smith WB,Gamble JR,Vadas MA,Lopez AF

    更新日期:1996-01-01 00:00:00

  • Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin.

    abstract::Surface receptors specific for either the C4b (CR1) or C3d (CR2) component of complement were examined on the neoplastic cells from 30 cases of non-Hodgkin's lymphoma of B-cell origin and on cells derived from 9 normal lymphoid tissues. Lymphocyte suspensions from non-neoplastic peripheral blood, tonsils, and lymph no...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cossman J,Jaffe ES

    更新日期:1981-07-01 00:00:00

  • Expression of the Fanconi anemia group A gene (Fanca) during mouse embryogenesis.

    abstract::About 80% of all cases of Fanconi anemia (FA) can be accounted for by complementation groups A and C. To understand the relationship between these groups, we analyzed the expression pattern of the mouse FA group-A gene (Fanca) during embryogenesis and compared it with the known pattern of the group-C gene (Fancc). Nor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Abu-Issa R,Eichele G,Youssoufian H

    更新日期:1999-07-15 00:00:00

  • Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.

    abstract::Cumulative evidence indicates that MYC, one of the major downstream effectors of NOTCH1, is a critical component of T-cell acute lymphoblastic leukemia (T-ALL) oncogenesis and a potential candidate for targeted therapy. However, MYC is a complex oncogene, involving both fine protein dosage and cell-context dependency,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336842

    authors: Bonnet M,Loosveld M,Montpellier B,Navarro JM,Quilichini B,Picard C,Di Cristofaro J,Bagnis C,Fossat C,Hernandez L,Mamessier E,Roulland S,Morgado E,Formisano-Tréziny C,Dik WA,Langerak AW,Prebet T,Vey N,Michel G,Gabert

    更新日期:2011-06-16 00:00:00

  • The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction.

    abstract::Interleukin-13 (IL-13) induced a potent mitogenic response in IL-3-dependent TF-1 cells and DNA synthesis to a lesser extent in MO7E and FDC-P1 cells. IL-13 stimulation of these lines, like IL-4 and insulin-like growth factor-1 (IGF-1), resulted in tyrosine phosphorylation of a 170-kD substrate. The tyrosine-phosphory...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wang LM,Michieli P,Lie WR,Liu F,Lee CC,Minty A,Sun XJ,Levine A,White MF,Pierce JH

    更新日期:1995-12-01 00:00:00

  • High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics.

    abstract::Inactivation of the retinoblastoma tumor-suppressor gene (RB-1) has been associated with tumorigenicity in various human malignancies. In chronic lymphoid leukemias of B-cell origin (B-CLL) an involvement of RB-1 has been suggested based on cytogenetic data. We examined RB-1 and its chromosomal locus 13q14 in 35 cases...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stilgenbauer S,Döhner H,Bulgay-Mörschel M,Weitz S,Bentz M,Lichter P

    更新日期:1993-04-15 00:00:00

  • Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

    abstract::The aim of this study was to investigate whether interleukin (IL)-6 induces the production of IL-1 and tumor necrosis factor (TNF) antagonists. Serial plasma samples were obtained from cancer patients participating in phase I and II trials of recombinant IL-6 administered as a 120-hour continuous intravenous (IV) infu...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Tilg H,Trehu E,Atkins MB,Dinarello CA,Mier JW

    更新日期:1994-01-01 00:00:00

  • Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes.

    abstract::We previously showed that granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) stimulate the differentiation of human monocytes into two phenotypically distinct types of macrophages. However, in vivo, not only CSF but also many other cytokines are produced under va...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Akagawa KS,Takasuka N,Nozaki Y,Komuro I,Azuma M,Ueda M,Naito M,Takahashi K

    更新日期:1996-11-15 00:00:00

  • Novel collectin/C1q receptor mediates mast cell activation and innate immunity.

    abstract::Mast cells play a critical role in innate immunity, allergy, and autoimmune diseases. The receptor/ligand interactions that mediate mast cell activation are poorly defined. The alpha2beta1 integrin, a receptor for collagens, laminins, decorin, E-cadherin, matrix metalloproteinase-1 (MMP-1), endorepellin, and several v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2218

    authors: Edelson BT,Stricker TP,Li Z,Dickeson SK,Shepherd VL,Santoro SA,Zutter MM

    更新日期:2006-01-01 00:00:00

  • Stimulation of persisting colonies in agar cultures by sera from patients with CML and AML.

    abstract::Cord plasma contains colony-stimulating activity (CSA) which stimulates the in vitro clonal growth of neutrophils, eosinophils, macrophages, erythrocytes, and persisting mast cells in semisolid cultures. Analysis of day 35 colonies in agar cultures was found to be a suitable means of demonstrating this activity and di...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brown RD,Yuen E,Kronenberg H,Rickard KA

    更新日期:1986-07-01 00:00:00

  • A randomized prospective comparison of chemotherapy to total body irradiation as initial treatment for the indolent lymphoproliferative diseases.

    abstract::One hundred eight consecutive patients with indolent lymphoproliferative diseases were stratified into chronic lymphocytic leukemia (CLL), stage III and IV well-differentiated lymphocytic lymphoma (WDLL), and stage III and IV follicular lymphoma (FL). Within each stratum, patients were prospectively and randomly assig...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Jacobs P,King HS

    更新日期:1987-06-01 00:00:00

  • Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.

    abstract::Reduced oxygenation of a variety of cells results in transcriptional upregulation of several genes, including the hematopoietic hormone erythropoietin, the angiogenic vascular endothelial growth factor (VEGF), and glycolytic enzymes such as aldolase. Recently, the heme protein cytochrome b558 of the nicotinamide adeni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wenger RH,Marti HH,Schuerer-Maly CC,Kvietikova I,Bauer C,Gassmann M,Maly FE

    更新日期:1996-01-15 00:00:00

  • A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

    abstract::Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the only potentially curative treatment available for patients with B-cell chronic lymphocytic leukemia (B-CLL). Here, we show that post-alloHSCT antibody repertoires can be mined for the discovery of fully human monoclonal antibodies to B-CLL cell-surfa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-222786

    authors: Baskar S,Suschak JM,Samija I,Srinivasan R,Childs RW,Pavletic SZ,Bishop MR,Rader C

    更新日期:2009-11-12 00:00:00

  • A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.

    abstract::This phase 2 study evaluated the efficacy and safety of the oral farnesyltransferase inhibitor tipifarnib in adults with refractory or relapsed acute myeloid leukemia (AML). Patients (n=252) received tipifarnib 600 mg twice a day for 21 days in 28-day cycles. Median age was 62 years; 99 (39%) patients were 65 years or...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-046144

    authors: Harousseau JL,Lancet JE,Reiffers J,Lowenberg B,Thomas X,Huguet F,Fenaux P,Zhang S,Rackoff W,De Porre P,Stone R,Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group.

    更新日期:2007-06-15 00:00:00

  • In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression.

    abstract::Thrombopoietin (TPO, c-mpl ligand) has emerged as a major hematopoietic cytokine stimulating megakaryocyte proliferation, endomitosis, and platelet production. This study shows that a single administration of an adenovirus (Ad) vector encoding TPO (AdCMV.TPO) abrogates thrombocytopenia induced in mice by carboplatin a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ohwada A,Rafii S,Moore MA,Crystal RG

    更新日期:1996-08-01 00:00:00

  • Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI.

    abstract::Mammalian erythrocytes undergo a unique maturation process in which they discard their nuclei and organelles and assume a flexible biconcave shape. We found that altered plasma lipoprotein metabolism can profoundly influence these events. Abnormal erythrocyte morphology was observed in hypercholesterolemic mice lackin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.5.1817

    authors: Holm TM,Braun A,Trigatti BL,Brugnara C,Sakamoto M,Krieger M,Andrews NC

    更新日期:2002-03-01 00:00:00

  • Thrombosis in the setting of obesity or inflammatory bowel disease.

    abstract::Obesity and inflammatory bowel disease (IBD) are systemic inflammatory disorders that predispose to arterial and venous thrombosis through similar prothrombotic mechanisms. Obesity and IBD are chronic risk factors that lead to a persistently elevated risk of thrombosis, although the thrombotic risk with IBD appears to...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-05-716720

    authors: Lentz SR

    更新日期:2016-11-17 00:00:00

  • Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma.

    abstract::Outcome in multiple myeloma is highly variable and a better understanding of the factors that influence disease biology is essential to understand and predict behavior in individual patients. In the present study, we analyzed combined genomewide DNA methylation and gene expression data of patients treated in the Medic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-03-487884

    authors: Kaiser MF,Johnson DC,Wu P,Walker BA,Brioli A,Mirabella F,Wardell CP,Melchor L,Davies FE,Morgan GJ

    更新日期:2013-07-11 00:00:00

  • Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production.

    abstract::Tumor necrosis factor-alpha (TNF-alpha) exerts two separate effects on neutrophils, stimulating effector functions while simultaneously inducing apoptosis. We examined here the involvement of caspases in neutrophil apoptosis and the effect of TNF-alpha-induced apoptosis on reactive oxygen production. Immunoblotting an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yamashita K,Takahashi A,Kobayashi S,Hirata H,Mesner PW Jr,Kaufmann SH,Yonehara S,Yamamoto K,Uchiyama T,Sasada M

    更新日期:1999-01-15 00:00:00

  • The rhesus macaque as an animal model for hemophilia B gene therapy.

    abstract::We have determined the 2905 nucleotide sequence of the rhesus macaque factor IX complementary DNA (cDNA) and found it to be greater than 95% identical to that of the human factor IX cDNA. The cDNA has a large 3' untranslated region like the human cDNA, but unlike the human cDNA has two polyadenylation sites 224 nucleo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lozier JN,Metzger ME,Donahue RE,Morgan RA

    更新日期:1999-03-15 00:00:00

  • p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia.

    abstract::Malignant cells from 52 children with acute lymphocytic leukemia (ALL) were investigated for inactivation of the p15ink4B and p16ink4 genes and other genetic alterations on chromosome 9p21. Homozygous deletions of the p15ink4B and/or the p16ink4 genes were detected in 16 cases and a further 9 cases showed evidence of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rasool O,Heyman M,Brandter LB,Liu Y,Grandér D,Söderhäll S,Einhorn S

    更新日期:1995-06-15 00:00:00

  • The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.

    abstract::Staining with CD14 and CD16 monoclonal antibodies will identify two monocyte subpopulations in human blood: a major population of regular monocytes, which strongly expresses the CD14 antigen (CD14++), and a minor population with weak expression of CD14 and expression of the CD16 antigen (CD14+/CD16+ cells). As shown h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fingerle G,Pforte A,Passlick B,Blumenstein M,Ströbel M,Ziegler-Heitbrock HW

    更新日期:1993-11-15 00:00:00

  • Platelet-associated complement C3 in immune thrombocytopenic purpura.

    abstract::Platelet-associated C3 (PA-C3) was measured with a quantitative immunofluorescence assay. With this assay, PA-C3 levels were determined for 78 normal volunteers, 30 patients with immune thrombocytopenic purpura (ITP), and 20 patients with nonimmune thrombocytopenias. Platelet-associated IgG (PA-IgG) levels were also m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Myers TJ,Kim BK,Steiner M,Baldini MG

    更新日期:1982-05-01 00:00:00

  • Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits.

    abstract::Tissue type plasminogen activator (t-PA) is an effective thrombolytic agent in experimental animals. The duration of the thrombolytic effect of infused t-PA is unknown. We compared the duration of the thrombolytic effect of t-PA with streptokinase by measuring the lysis of 125I-fibrin-labeled thrombi in rabbit jugular...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Agnelli G,Buchanan MR,Fernandez F,Van Ryn J,Hirsh J

    更新日期:1985-08-01 00:00:00